Article Text

Download PDFPDF
General practitioners’ advice to use topical rather than oral ibuprofen resulted in equivalent effects on chronic knee pain

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

M Underwood

Professor M Underwood, University of Warwick, Coventry, UK; M.Underwood@warwick.ac.uk

STUDY DESIGN

Design:

randomised controlled trial (Topical or Oral Ibuprofen [TOIB]).

Allocation:

concealed.*

Blinding:

blinded (data collectors).*

STUDY QUESTION

Setting:

26 general practices in the UK.

Patients:

282 patients ⩾50 years of age (mean age 63 y, 54% women) with knee pain (97% with osteoarthritis). Exclusion criteria included history of, or awaiting, knee replacement, and recent knee injury.

Intervention:

the patient’s general practitioner prescribed or recommended preferential use of over-the-counter topical ibuprofen, applied according to manufacturer’s instructions (eg, 0.5 g per knee up to 3 times/d, equivalent to 75 mg/d of ibuprofen using a 5% preparation) (n = 138), or oral ibuprofen, up to 1.2 g/day (n = 144). Increased dose, …

View Full Text

Footnotes

  • Source of funding: Health Technology Assessment Programme; Goldshield Pharmaceuticals supplied starter packs of topical ibuprofen.